DISCORDANCE OF EPSTEIN-BARR VIRUS (EBV) SPECIFIC HUMORAL AND CELLULAR IMMUNITY IN PATIENTS WITH MALIGNANT-LYMPHOMAS - ELEVATED ANTIBODY TITERS AND LOWERED INVITRO LYMPHOCYTE-REACTIVITY

被引：0
|
作者：
TENNAPEL, CHH
THE, TH
VANEGTENBIJKER, J
GAST, GCD
HALIE, MR
LANGENHUYSEN, MMAC
机构：
[1] STATE UNIV GRONINGEN, CLIN IMMUNOL UNIT, GRONINGEN, NETHERLANDS
[2] FREE UNIV AMSTERDAM, DEPT INTERNAL MED, DIV HAEMATOL, AMSTERDAM, NETHERLANDS
[3] STATE UNIV GRONINGEN, DEPT INTERNAL MED, DIV HAEMATOL, GRONINGEN, NETHERLANDS
来源：
CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 1978年 / 34卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：338 / 346
页数：9
相关论文
共 27 条
  • [1] High incidence of elevated antibody titers to Epstein-Barr virus in patients with uveitis
    Touge, C
    Agawa, H
    Sairenji, T
    Inoue, Y
    ARCHIVES OF VIROLOGY, 2006, 151 (05) : 895 - 903
  • [2] High incidence of elevated antibody titers to Epstein-Barr virus in patients with uveitis
    C. Touge
    H. Agawa
    T. Sairenji
    Y. Inoue
    Archives of Virology, 2006, 151 : 895 - 903
  • [3] CHARACTERISTIC OF THE EPSTEIN-BARR VIRUS-ASSOCIATED MALIGNANT-LYMPHOMAS IN CHERNOBYL REGION PATIENTS
    BUTENKO, ZA
    KINDZELSKY, LP
    BUTENKO, AK
    SMIRNOVA, IA
    NAUMENKO, OI
    KISHINSKAYA, EG
    SANUKOVA, LN
    EKSPERIMENTALNAYA ONKOLOGIYA, 1992, 14 (06): : 36 - 40
  • [4] Elevated Antibody Titers to Epstein-Barr Virus and Cytomegalovirus in Patients with Drug-Induced Lupus
    Knudsen, Julie
    Trier, Nicole Hartwig
    Draborg, Anette Holck
    Nielsen, Christoffer Tandrup
    Jacobsen, Soren
    Hojrup, Peter
    Houen, Gunnar
    VIRUSES-BASEL, 2023, 15 (04):
  • [5] Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma
    Shao, JY
    Li, YH
    Gao, HY
    Wu, QL
    Cui, NJ
    Zhang, L
    Cheng, G
    Hu, LF
    Ernberg, I
    Zeng, YX
    CANCER, 2004, 100 (06) : 1162 - 1170
  • [6] Evaluation of the clinical significance of Epstein-Barr virus (EBV)specific immunity among healthy EBV carriers and patients with EBV associated malignancies.
    Heller, KN
    Seyoum, B
    Upshaw, J
    Zebroski, H
    Münz, C
    JOURNAL OF INVESTIGATIVE MEDICINE, 2005, 53 (02) : S387 - S388
  • [7] EPSTEIN-BARR VIRUS (EBV)-SPECIFIC CELL-MEDIATED AND HUMORAL IMMUNE-RESPONSES IN ATAXIA-TELANGIECTASIA PATIENTS
    MASUCCI, G
    BERKEL, I
    MASUCCI, MG
    ERNBERG, I
    SZIGETI, R
    ERSOY, F
    SANAL, O
    YEGIN, O
    HENLE, G
    HENLE, W
    PEARSON, G
    AMAN, P
    KLEIN, G
    JOURNAL OF CLINICAL IMMUNOLOGY, 1984, 4 (05) : 369 - 382
  • [8] EPSTEIN-BARR VIRUS-SPECIFIC ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY IN PATIENTS WITH BURKITTS-LYMPHOMA
    PEARSON, GR
    QUALTIERE, LF
    KLEIN, G
    NORIN, T
    BAL, IS
    INTERNATIONAL JOURNAL OF CANCER, 1979, 24 (04) : 402 - 406
  • [9] Anti-Epstein-Barr virus (EBV) antibodies in multiple sclerosis patients show differential titers against EBV lifecycle proteins but no elevated antibody titers against potential EBV related MS peptides such as GlialCAM or CRYAB
    Vasilenko, Nicole
    Michel, Tanja
    Tieck-Fernandez, Maria
    Schembecker, Sonja
    Ruschil, Christoph
    Dulovic, Alex
    Kowarik, Markus
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 501 - 501
  • [10] Restoration of the antiviral cellular immunity by enhanced Epstein-Barr virus (EBV)-specific endogenous effector T-cell responses after rituximab therapy
    Tischer-Zimmermann, S.
    Santamorena, M. M.
    Bonifacius, A.
    Doering, M.
    Kalinke, U.
    Blasczyk, R.
    Maecker-Kolhoff, B.
    Eiz-Vesper, B.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2022, 52 : 357 - 357
123